← Back to headlines
Lyon Biotech Seeks Funding for Ebola Variant Treatment
A biotech company based in Lyon is confident it can develop a treatment for Ebola virus variants within 24 months and is requesting public financial support to prepare for a future epidemic.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
